BHSC logo

BioHarvest Sciences Inc. Stock Price

CNSX:BHSC Community·CA$137.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BHSC Share Price Performance

CA$7.95
-0.75 (-8.62%)
CA$7.95
-0.75 (-8.62%)
Price CA$7.95

BHSC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential low.

3 Risks
2 Rewards

BioHarvest Sciences Inc. Key Details

US$22.4m

Revenue

US$10.3m

Cost of Revenue

US$12.1m

Gross Profit

US$29.3m

Other Expenses

-US$17.2m

Earnings

Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
-0.99
54.00%
-76.65%
28.8%
View Full Analysis

About BHSC

Founded
n/a
Employees
n/a
CEO
Ilan Sobel
WebsiteView website
www.bioharvest.com

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Recent BHSC News & Updates

Recent updates

No updates